Lyzalon (New Formulation)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LYZALON pregabalin Consumer Medicine Information What is […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LYZALON pregabalin Consumer Medicine Information What is […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AVANZA® Mirtazapine 30mg Consumer Medicine Information What […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KEVTAM levetiracetam Consumer Medicine Information What is […] NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LORAZEPAM MYLAN Contains the active ingredient lorazepam […] In late summer, as researchers accelerated the first clinical trials of COVID-19 vaccines for humans, a group of scientists in […] April 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a front-runner in […] 21 December 2020 — AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage […] FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 […]Medications
Lyzalon (New Formulation)
Avanza Tablets (MSD)
Kevtam (new formula)
Lorazepam Mylan
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
Tagrisso Approved in the US for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer
FDA Approves Klisyri
Copyright © 2024